[ALNY] YoY Quarter Result on 30-Sep-2012 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
05-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -50.52%
YoY- -47.33%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 6,324 10,972 8,991 16,759 20,791 27,668 24,249 -20.06%
PBT -76,792 -43,922 -31,956 -19,502 -13,237 -9,332 -9,760 41.00%
Tax -1,610 67 -2,270 -2,543 -930 298 -552 19.52%
NP -76,792 -43,989 -29,686 -19,502 -13,237 -9,630 -9,208 42.38%
Tax Rate - - - - - - - -
Total Cost 83,116 54,961 38,677 36,261 34,028 37,298 33,457 16.36%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin -1,214.29 -400.92 -330.17 -116.37 -63.67 -34.81 -37.97 78.11%
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
EPS -0.91 -0.58 -0.48 -0.38 -0.31 -0.23 -0.22 26.68%
EPS Diluted -0.91 -0.58 -0.48 -0.38 -0.31 -0.23 -0.22 26.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.